Doximity, Inc. (NASDAQ: DOCS) had its price target raised by analysts at JPMorgan Chase & Co. from $30.00 to $48.00. They now have a "neutral" rating on the stock.
Zacks.com featured highlights Doximity, Impinj and Innodata [Yahoo! Finance]
TikTok ‘dermfluencers' have medical students flocking to dermatology, where they can make half a million dollars a year and work four days a week [Yahoo! Finance]
TikTok ‘dermfluencers' have medical students flocking to dermatology, where they can make half a million dollars a year and work four days a week [Fortune]
Polen U.S. Small Company Growth Strategy Exited Doximity (DOCS) Due to Multiple Factors [Yahoo! Finance]